Novo Nordisk is Rated Supersector Leader

Novo Nordisk ranks as best-in-class in healthcare - one of 18 global supersectors - in Dow Jones Sustainability Indexes, the world's leading indexes for sustainability-driven investment portfolios. This ranking, effective at the opening of equity markets on 24 September 2007, is a result of the latest global analysis of corporate sustainability leadership, based on a thorough analysis of companies' economic, environmental and social performance. The analysis concludes that "Novo Nordisk is the leading company in terms of sustainability in the pharmaceutical industry. Sustainability is an integral part of its corporate strategy and business organisation."

Novo Nordisk's performance is found to be particularly strong in the social dimension - human capital development, corporate citizenship/philanthropy, social reporting, animal testing and bioethics. Also the company's responsible sourcing, environmental management and climate strategy achieve high scores.

- This rating is important for us. Our ambition is to be the leading healthcare company in terms of sustainability, and we regard the ranking in Dow Jones Sustainability Indexes as recognition of the results we have achieved so far, says Lise Kingo, Executive Vice President and Chief of Staffs, Novo Nordisk.

Read the Novo Nordisk press release, 11.03.2007 

Source: BioTechNews Denmark, 13.09.2007